Phase
Condition
Depression
Treatment
Ketamine-assisted psychotherapy
Clinical Study ID
Ages 18-64 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Self-identifying Latinx, Spanish-speaking 2. Adults 18-64 years 3. Meet DSM-5criteria for major depressive disorder as evaluated by study clinician 4.Montgomery-Asberg depression scale (MADRS) score of 20 or above at baseline 4.Participants must have an MGB psychiatrist and primary care provider.
Exclusion
Exclusion Criteria:
History of primary psychotic disorder, by history
History Bipolar I disorder, by history
Unstable complex PTSD, as assessed by study clinician
History of dissociative identity disorder
History of neurocognitive disorder
History of severe and/or recent substance use disorder, by history and as assessedby study clinician after clinical evaluation and interview
Uncontrolled hypertension, tachycardia, or unstable cardiopulmonary disease, byhistory a. Blood pressure on initial screen must be <140/90 mmHg.
History of aortic dissection
History of myocardial infarction
History of aneurysm
History of hepatic impairment.
History of epilepsy
History of prior hypersensitivity to ketamine
Body Mass Index greater than 35
Body Mass Index less than 18.5
Are pregnant, breastfeeding, or planning to become pregnant within 12 weeks oftreatment completion
Enrolled in other clinical trial for the treatment of depression or other behavioralhealth diagnosis
Inability to provide consent.
Study Design
Connect with a study center
Massachusetts General Hospital, Chelsea
Chelsea, Massachusetts 02114
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.